EGFR/HER2-IN-7 is a potent anticancer agent with high selectivity toward cancer cells, specifically targeting breast cancer MCF-7 cells; it functions as a multi-target inhibitor of EGFR, HER2 kinase, and DHFR, inducing cell cycle arrest at the G1/S phase and promoting apoptosis.